The epidemiological surveillance of malignant mesothelioma in Italy (1993-2015): methods, findings, and research perspectives.

La sorveglianza epidemiologica dei casi di mesotelioma maligno in Italia (1993-2015): metodi, risultati e prospettive di ricerca.

Journal

Epidemiologia e prevenzione
ISSN: 1120-9763
Titre abrégé: Epidemiol Prev
Pays: Italy
ID NLM: 8902507

Informations de publication

Date de publication:
Historique:
entrez: 7 5 2020
pubmed: 7 5 2020
medline: 15 12 2020
Statut: ppublish

Résumé

as a legacy of the large asbestos consumption until the definitive ban in 1992, Italy had to tackle a real epidemic of asbestos related diseases. The Italian National Registry of Malignant Mesotheliomas (ReNaM) is a permanent surveillance system of mesothelioma incidence, with a regional structure. Aims, assignments and territorial network of ReNaM are described, as well as data collection, recording and coding procedures. to describe the Italian epidemiological surveillance system of mesothelioma incidence, to provide updated data about occurrence of malignant mesothelioma in Italy, and to discuss goals, attainments, and expectations of registering occupational cancer. analysis of data by malignant mesothelioma incident cases surveillance system. Italy, network of regional surveillance system, all Italian regions. a Regional Operating Centre (COR) is currently established in all the Italian regions, actively searching incident malignant mesothelioma cases from health care institutions. Occupational history, lifestyle habits, and residential history are obtained using a standardized questionnaire, administered to the subject or to the next of kin by a trained interviewer. The extent of dataset, epidemiological parameters, and occupations involved are reported updated at 31.12.2016, and standardized incidence rates are calculated. at December 2016, ReNaM has collected 27,356 malignant mesothelioma cases, referring to the period of incidence between 1993 and 2015. The modalities of exposure to asbestos have been investigated for 21,387 (78%) and an occupational exposure has been defined for around 70% of defined cases (14,818). the Italian experience shows that epidemiological systematic surveillance of asbestos related diseases incidence has a key importance for assessing and monitoring the public health impact of occupational and/or environmental hazards, programming preventive interventions, including remediation plans and information campaigns, and supporting the efficiency of insurance and welfare system. Monitoring the incidence of malignant mesothelioma through a specialized cancer registry is essential to follow-up the health effects of changing modalities and extent of occupational exposures over years and of environmental contamination. Such consolidated surveillance system is recommended also for occupational cancers with low aetiological fraction.

Sections du résumé

BACKGROUND BACKGROUND
as a legacy of the large asbestos consumption until the definitive ban in 1992, Italy had to tackle a real epidemic of asbestos related diseases. The Italian National Registry of Malignant Mesotheliomas (ReNaM) is a permanent surveillance system of mesothelioma incidence, with a regional structure. Aims, assignments and territorial network of ReNaM are described, as well as data collection, recording and coding procedures.
OBJECTIVES OBJECTIVE
to describe the Italian epidemiological surveillance system of mesothelioma incidence, to provide updated data about occurrence of malignant mesothelioma in Italy, and to discuss goals, attainments, and expectations of registering occupational cancer.
DESIGN METHODS
analysis of data by malignant mesothelioma incident cases surveillance system.
SETTING AND PARTICIPANTS METHODS
Italy, network of regional surveillance system, all Italian regions.
MAIN OUTCOME MEASURES METHODS
a Regional Operating Centre (COR) is currently established in all the Italian regions, actively searching incident malignant mesothelioma cases from health care institutions. Occupational history, lifestyle habits, and residential history are obtained using a standardized questionnaire, administered to the subject or to the next of kin by a trained interviewer. The extent of dataset, epidemiological parameters, and occupations involved are reported updated at 31.12.2016, and standardized incidence rates are calculated.
RESULTS RESULTS
at December 2016, ReNaM has collected 27,356 malignant mesothelioma cases, referring to the period of incidence between 1993 and 2015. The modalities of exposure to asbestos have been investigated for 21,387 (78%) and an occupational exposure has been defined for around 70% of defined cases (14,818).
CONCLUSIONS CONCLUSIONS
the Italian experience shows that epidemiological systematic surveillance of asbestos related diseases incidence has a key importance for assessing and monitoring the public health impact of occupational and/or environmental hazards, programming preventive interventions, including remediation plans and information campaigns, and supporting the efficiency of insurance and welfare system. Monitoring the incidence of malignant mesothelioma through a specialized cancer registry is essential to follow-up the health effects of changing modalities and extent of occupational exposures over years and of environmental contamination. Such consolidated surveillance system is recommended also for occupational cancers with low aetiological fraction.

Identifiants

pubmed: 32374111
doi: 10.19191/EP20.1.P023.014
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-30

Investigateurs

Enrico Detragiache (E)
Franco Merletti (F)
Manuela Gangemi (M)
Antonella Stura (A)
Carol Brentisci (C)
Marco Gilardetti (M)
Dario Mirabelli (D)
Lucia Benfatto (L)
Pier Aldo Canessa (PA)
Davide Malacarne (D)
Giovanna Mazzucco (G)
Maria Giuseppina Campi (MG)
Dario Consonni (D)
Barbara Dallari (B)
Angela Cecilia Pesatori (AC)
Luciano Riboldi (L)
Paolo Girardi (P)
Vittoria Bressan (V)
Francesco Gioffrè (F)
Maria Nicoletta Ballarin (MN)
Enzo Merler (E)
Flavia D'Agostin (F)
Paola De Michieli (P)
Lucia Mangone (L)
Cinzia Storchi (C)
Orietta Sala (O)
Anna Maria Badiali (AM)
Valentina Cacciarini (V)
Lucia Giovannetti (L)
Andrea Martini (A)
Roberto Calisti (R)
Fabrizio Stracci (F)
Marina Davoli (M)
Valeria Ascoli (V)
Fulvio Cavariani (F)
Laura Ancona (L)
Annamaria Di Giammarco (A)
Annalisa Annunziata (A)
Simona Menegozzo (S)
Francesco Napolitano (F)
Concetta Paola Pelullo (CP)
Luigi Vimercati (L)
Santo Giovanni Lio (SG)
Giuseppe Cascone (G)
Graziella Frasca (G)
Maria Concetta Giurdanella (MC)
Caterina Martorana (C)
Carmela Nicita (C)
Concetta Patrizia Rollo (CP)
Eugenia Spata (E)
Gabriella Dardanoni (G)
Salvatore Scondotto (S)
Virgilio Nieddu (V)
Maurizio Pergola (M)
Sergio Stecchi (S)

Auteurs

Alessandro Marinaccio (A)

Department of occupational and environmental medicine, epidemiology and hygiene, Italian Workers Compensation Authority (Inail), Roma (Italy); a.marinaccio@inail.it.

Marisa Corfiati (M)

Department of occupational and environmental medicine, epidemiology and hygiene, Italian Workers Compensation Authority (Inail), Roma (Italy).

Alessandra Binazzi (A)

Department of occupational and environmental medicine, epidemiology and hygiene, Italian Workers Compensation Authority (Inail), Roma (Italy).

Davide Di Marzio (D)

Department of occupational and environmental medicine, epidemiology and hygiene, Italian Workers Compensation Authority (Inail), Roma (Italy).

Michela Bonafede (M)

Department of occupational and environmental medicine, epidemiology and hygiene, Italian Workers Compensation Authority (Inail), Roma (Italy).

Marina Verardo (M)

Regional Operating Center of Valle d'Aosta, Valle d'Aosta Local Health Unit, Aosta (Italy).

Enrica Migliore (E)

Regional Operating Center of Piedmont, Unit of Cancer Prevention, University of Turin and CPO-Piemonte, Turin (Italy).

Valerio Gennaro (V)

Regional Operating Center of Liguria, Operative unit of Epidemiology, IRCCS University Hospital San Martino, National Cancer Research Institute (IST), Genoa (Italy).

Carolina Mensi (C)

Regional Operating Center of Lombrady, IRCCS Ca' Granda Foundation, Ospedale Maggiore Policlinico and University of Milan, Milan (Italy).

Gert Schallemberg (G)

Regional Operating Center of the Province of Trento, Provincial Unit of Health, hygiene and occupational medicine, Trento (Italy).

Guido Mazzoleni (G)

Regional Operating Center of the Province of Bolzano, Alto Adige Local Health Unit, Bolzano (Italy).

Ugo Fedeli (U)

Regional Operating Center of Veneto, Epidemiological Department, Azienda Zero, Padua (Italy).

Corrado Negro (C)

Regional Operating Center of Friuli Venezia Giulia, University of Trieste, Clinical Unit of Occupational Medicine, Trieste General Hospitals, Trieste (Italy).

Antonio Romanelli (A)

Regional Operating Center of Emilia-Romagna, Public Health Department, Local Health Unit, Reggio Emilia (Italy).

Elisabetta Chellini (E)

Regional Operating Center of Tuscany, Unit of Environmental and Occupational Epidemiology, Cancer Prevention and Research Institute, Florence (Italy).

Iolanda Grappasonni (I)

Regional Operating Center of Marche, Hygienistic, Environmental and Health Sciences Department, School of Sciences of the drug and the products of health, University of Camerino, Camerino (Italy).

Cristiana Pascucci (C)

Regional Operating Center of Marche, Hygienistic, Environmental and Health Sciences Department, School of Sciences of the drug and the products of health, University of Camerino, Camerino (Italy).

Gabriella Madeo (G)

Regional Operating Center of Umbria, Department of Experimental Medicine, Public Health section, University of Perugia, Perugia (Italy).

Elisa Romeo (E)

Regional Operating Center of Lazio, Department of Epidemiology, Lazio Region, Rome (Italy).

Luana Trafficante (L)

Regional Operating Center of Abruzzo, Occupational Medicine Unit, Local Health Unit, Pescara (Italy).

Francesco Carrozza (F)

Regional Operating Center of Molise, Oncology Unit, Cardarelli Hospital, Campobasso (Italy).

Italo Francesco Angelillo (IF)

Regional Operating Center of Campania, Department of Experimental Medicine, Second University of Naples, Naples (Italy).

Domenica Cavone (D)

Regional Operating Center of Puglia, Department of Interdisciplinary Medicine, Section of Occupational Medicine "B. Ramazzini", University of Bari, Bari (Italy).

Gabriella Cauzillo (G)

Regional Operating Center of Basilicata, Epidemiological Regional Center, Potenza (Italy).

Federico Tallarigo (F)

Regional Operating Center of Calabria, Public Health Unit, Crotone (Italy).

Rosario Tumino (R)

Regional Operating Center of Sicily, Cancer Registry, Provincial Health Department of Ragusa and Sicily Regional Epidemiological Observatory, Ragusa (Italy).

Massimo Melis (M)

Regional Operating Center of Sardegna, Regional Epidemiological Center, Cagliari (Italy).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH